Fintel on MSN
William Blair initiates coverage of Viridian Therapeutics (VRDN) with outperform recommendation
Fintel reports that on December 3, 2025, William Blair initiated coverage of Viridian Therapeutics (NasdaqCM:VRDN) with a ...
William Blair starts coverage of Viridian, citing veligrotug's advantages over Tepezza and key 2026 catalysts, including FDA ...
Dollar Tree shares climbed Wednesday after the discount retailer posted earnings that topped estimates as executives said it ...
TipRanks on MSN
NVDA vs. PLTR: Which AI Stock Will Lead the 2026 Breakout?
As we near the end of 2025, AI stocks Nvidia ($NVDA) and Palantir Technologies ($PLTR) will be remembered for their strong momentum and investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback